We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

A Milestone Is Reached For New Leukemia Drug

News   Nov 20, 2019 | Original story from Cold Spring Harbor Laboratory

 
A Milestone Is Reached For New Leukemia Drug

Bioluminescence imaging of mice whose cancer cells were tagged with a firefly-derived enzyme shows how the drug YKL-05-099 blocks the SIK3 pathway to slow the progression of leukemia. Credit: Vakoc lab/CSHL, 2019.

 
 
 

RELATED ARTICLES

New Markers for Triple Negative Breast Cancer

News

Two biomarkers – a 44-gene DNA Damage Response (DDIR) signature and stromal tumor-infiltrating lymphocytes (sTILs) – can serve as prognostic markers in people diagnosed with triple negative breast cancer, according to a new study.

READ MORE

Secrets of Herbal Antidepressant Synthesis Are Uncovered

News

A new collaboration by scientists from German and Canadian research institutes has shed light on the genes involved in the biosynthesis of hypericin.

READ MORE

Better Understanding of Irregular Heartbeat May Lead to Improved Treatment

News

Researchers at Imperial have shown how the chaotic electrical signals underlying irregular heart rhythms lead to the failure of standard treatments.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE